Dana Shares Drop 15% as Analysts Trim Targets Before Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
DAN fell 15.4% over the past week to $22.89, a sharp move that stands out against a median gain of roughly 0.6% for its closest automotive parts peers, and arrives three days before the company reports Q3 results on November 6.
The stock's underperformance is not hard to explain: a wave of target cuts landed on the same days as the sell-off. Four analysts moved in the past week alone. Barclays lowered its target to $33 while holding Equal-Weight. BNP Paribas cut to $34 from $38, maintaining Outperform. RBC Capital trimmed to $32 from $37, also keeping Outperform. UBS went to $34 from $36, staying at Buy. The mean target across the consensus is now $36.33, implying around 59% above the current price. The Street broadly still believes in the recovery thesis, but has been reducing the magnitude of that conviction with each successive note. All four of these cuts came without a rating downgrade, a pattern that reads less as alarm and more as a reset of near-term expectations ahead of the print.
The debate between optimists and sceptics centres on costs versus cycle. The bull case rests on real delivery: management exceeded its cost-saving targets with $250 million in cuts and subsequently raised the cumulative savings goal to $325 million through 2026, while peer multiple re-rating to 5.0x 2026 EBITDA from 4.5x has given the story a sentiment tailwind. The bear case is blunter. Management's own guidance points to roughly flat sales of $7.5 billion for 2026, and the auto cycle exposes Dana to OEM pricing pressure, commodity costs, and volume risk that cost savings can only partially offset. The EPS momentum factor rank sits in just the 9th percentile over the past 30 days, which reflects how far forward estimates have been revised down.
Short positioning does not tell a particularly charged story ahead of the report. Short interest dipped 6.4% over the past week to 3.8% of the free float, a modest level that carries little squeeze relevance. The borrow market is open: cost to borrow has climbed to 0.58% from 0.35% a month ago, a notable percentage move but still low in absolute terms. Availability, while tighter than it was two weeks ago at roughly 1,878% of short interest, remains exceptionally loose. There is no meaningful friction in the lending market. Icahn Partners Master Fund, which filed a Schedule 13D in early 2025 at 9.85% of the class, has not updated its position since June 2025; the 13D remains on the register, but the current stake is unknown, as holders dropping below 5% are under no obligation to file again.
The Q3 print will test whether Dana's cost discipline can hold margins in a quarter where the automotive cycle is still providing headwinds, and whether the company's own volume trajectory is any better than the flat guidance management set for the year.
Stocks in this article
See the live data behind this article on ORTEX.
Open DAN on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:36
- Data as of
- 3 Nov 2026, 04:39
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.